Work

Benefit of continued pirfenidone treatment following hospitalisation within the first 6 months of therapy—Ad hoc analysis from three phase 3 trials in patients with idiopathic pulmonary fibrosis (IPF)

Year: 2015

Type: conference-abstract

DOI: 10.1183/13993003.congress-2015.oa4491

Authors: Steven Nathan, Carlo Albera, Williamson Bradford, Ulrich Costabel, Roland Du Bois, Elizabeth Fagan, Robert Fishman, Ian Glaspole, Marilyn Glassberg, Kenneth Glasscock, Lisa Lancaster, David Lederer, Zhengning Lin, Carlos Pereira, Jeffrey Swigris, Dominique Valeyre, Paul Noble, Athol Wells

Institutions: Inova Fairfax Hospital, University of Turin, Ruhrlandklinik, Imperial College London, The Alfred Hospital, Monash University, University of Miami, Vanderbilt University Medical Center, Columbia University Irving Medical Center, Universidade Federal de São Paulo, National Jewish Health, Assistance Publique – Hôpitaux de Paris, Hôpital Avicenne, Cedars-Sinai Medical Center, Royal Brompton Hospital

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2474275155

Cites:

Cited by:

Related to: 10